The Medicare Advantage market is undergoing a period of correction after rapid growth in the early part of the decade. Last year showed the first signs of a tempering of this growth, and the cooldown continued into this year.
Efforts to reduce Medicaid program costs are gaining momentum under the Trump Administration. We discuss potential policies, the financial impacts for health plans, and steps to navigate these changes.
Amid regulatory uncertainty, Medicare Advantage leaders’ priorities reveal a focus on weathering recent disruption, with an eye toward a more favorable forecast for the coming year.
